In a decision hailed by some as a free-speech victory and by others as a ruling that gives drugmakers free rein to promote their goods off-label, federal appeals judges threw out the conviction of a former sales representative with Orphan Medical Inc. (acquired by Jazz Pharmaceuticals plc), who claimed his First Amendment rights were violated.